Organization
Maze Therapeutics
1 clinical trial
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of MZE001 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-21